Qurse Revand for MASLD: A Randomized Controlled Safety and Efficacy Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the safety, efficacy of the Unani compound formulation Qurse Revand compared to a placebo in adult participants with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Epistemonikos ID: a2e11a3bd8ba098cb9ec0997d8b4c41e41412094
First added on: Oct 29, 2026